Company AnalysisAnalysis as of 03 Apr 2026

AI-generated · cited to primary sources · not investment advice · How we research

Park Medi World

BSE:544645
NSE:PARKHOSPS

Our verdict on Park Medi World isn’t the consensus take — see where we landed, and the one risk the bull case glosses over.

See the verdict — free →
01 · Management Credibility

Does management do what it says?

Ayushman Bharat Tariff Revision

The company expects the full impact of the CGHS rate hike (estimated at 12-15%) to reflect in finances by the second half of the next financial year. — target: 12% to 15% rate hike impact

But generally, the overall rate hike, what we envisage has been about 12% to 15%. And the effectivity of that will come probably in the, as you said, second half of the next financial year.

Park Medi World · Concall Transcript · Feb 2026 · p.18
Bed Occupancy Rate

The company aims to reach optimum occupancy of 75% to 80% at the new 360-bed Agra facility within the next three years. — target: 75% to 80% occupancy

See, currently our main focus would be that, in 360 bed, we reach the optimum occupancy of about 75% to 80%... we look at ramping up the occupancy to about 75% to 80% in the coming three years.

Park Medi World · Concall Transcript · Feb 2026 · p.21
Brownfield Expansion Over Greenfield for ROE

Management is focusing on increasing bed capacity at the Ambala facility to 450 beds. — target: 450 beds

Increasing bed capacity in Ambala (450 beds)

Park Medi World · Investor PPT · Feb 2026 · p.29
Payor Mix Dictates Revenue Predictability

Management expects the receivable cycle (TAT) to reduce from 4.5 months to 4 months by the end of the financial year, and eventually to 3.5 months. — target: 3.5 to 4 months TAT (+1 more commitment)

And what we are expecting by end of this financial year, I'm hoping this four and a half month TAT will come down to four. And maybe going forward, it will be close to three and a half months.

Park Medi World · Concall Transcript · Feb 2026 · p.14
Massive Capacity Addition Cycle

The company plans to add 660 beds in FY26, reaching a total capacity of approximately 3,910 beds. — target: 3,910 beds (+4 more commitments)

So in FY ‘26 itself, from 3,250 we will be adding 660 beds more, which will take us to approximately 3,910 beds.

Park Medi World · Concall Transcript · Feb 2026 · p.6

See the full cited Management analysis of Park Medi World

Create free account →
02 · Business Model

How durable is the business?

Doctor Ecosystem Is Competitive Moat
60/100

The doctor-led management model continues to yield industry-low attrition rates of 18.9% at the consultant level. (1 stable)

So Shreya, all our consultants are full-time. And if we employ only full-time doctors, there is no visiting consultant policy with us. ... In the consultant level, our attrition rate has been the least in the industry, which is about 18.9%.

Park Medi World · Concall Transcript · Feb 2026 · p.15
Payor Mix Dictates Revenue Predictability
45/100

The share of revenue from government panels decreased slightly from 84% to 83% as the company intentionally shifts toward a higher mix of private insurance and self-pay patients. (1 contracting, 1 stable across 2 engines)

If I talk about as of 31st December, our payer mix, you know, that relate to government scheme that came down to 83% from 84%.

Park Medi World · Concall Transcript · Feb 2026 · p.12
Case Mix Determines ARPOB Trajectory
30/100

Internal Medicine's share of revenue continues to contract as the company successfully diversifies into higher-value surgical specialties. (1 contracting across 3 engines)

Internal Medicine, 30% (H1FY26)

Park Medi World · Investor PPT · Feb 2026 · p.21
Average Revenue Per Occupied Bed

The company's average revenue per occupied bed (ARPOB) reached Rs. 27,406, reflecting a steady increase driven by a shift toward more complex medical procedures. — Hospital Services (ARPOB)

ARPOB (INR): 27,406 (9M FY26)

Park Medi World · Investor PPT · Feb 2026 · p.33
Other Findings

Park Medi World is a major healthcare provider in North India, operating 14 multi-specialty hospitals with over 3,250 beds. They focus on making high-quality medical care like robotic surgeries and organ transplants affordable for middle-income families. The company primarily makes money by treating patients through government-backed insurance schemes and private payments in states like Haryana, Delhi, and Punjab. (+3 more findings)

Urology, 11% (H1FY26)

Park Medi World · Investor PPT · Feb 2026 · p.21

See the full cited Business Model analysis of Park Medi World

Create free account →
03 · Future Growth

Where does growth come from?

M&A of Regional Hospital Chains
59/100

The company continues its strategy of acquiring distressed assets through the IBC process (e.g., KP Institute in Agra), which maintains a low capital entry point and supports high ROCE (21% in H1 FY26). (1 steady across 1 signal, 1 leading indicator)

Acquisition of Febris Multi-Speciality Hospital at Narela, New Delhi... Acquisition of Agra-based KP Institute of Medical Sciences... Acquired 100% stake in KPIMS in an all-cash transaction of ~₹245 crore

Park Medi World · Investor PPT · Feb 2026 · p.7
Insurance Penetration Accelerating
59/100

The company is successfully migrating its payer mix toward higher-margin private insurance, which has grown from 16% to 17% and is targeted to reach 25%. (1 steady across 1 signal)

Today, we are 83%-17%. I believe by the end of this financial year, we will probably be 80%-20%. And going forward in a year's time, we will be 75%-25%.

Park Medi World · Concall Transcript · Feb 2026 · p.13
Other Findings
57/100

Patient volume is showing strong momentum, with a 24% increase in total footfalls (inpatient and outpatient) over the first nine months of the year. — Total Footfall (IPD & OPD): 24% YoY (+2 more signals)

IPD and OPD together, it was 5.32 lakhs patient last year that grown to 6.6 lakhs in the first nine months of the current year and we registered a growth of 24% in footfall.

Park Medi World · Concall Transcript · Feb 2026 · p.7
Medical Tourism Growing at 20%+ CAGR
55/100

The company is targeting international patients by creating a dedicated marketing department to tap into the growing medical tourism market. — Medical Tourism Growth: 20% CAGR (Market Trend)

Focus on international patients with creation of International marketing department

Park Medi World · Investor PPT · Feb 2026 · p.30
Tier-2/3 City Hospital Expansion
55/100

Park Medi World is entering the Uttar Pradesh market aggressively, planning to reach 1,060 beds in the state within 24 months to tap into the large underserved population. (+1 more signal)

It is very striking to note that from literally zero, we will be 1,060 bed capacity in UP by FY ’28, in 24 months' time, which is quite remarkable.

Park Medi World · Concall Transcript · Feb 2026 · p.19

See the full cited Future Growth analysis of Park Medi World

Create free account →
04 · Risk

What could break the thesis?

Payor Mix Dictates Revenue Predictability
77/100

The risk is easing as the company is seeing a structural shift toward private insurance (TPA) and self-pay, which improved from 16% to 17% and is projected to reach 25% in a year. Additionally, a significant CGHS rate hike of 12-15% is expected to improve margins. (2 easing, 1 intensifying, 1 high-severity)

If I talk about as of 31st December, our payer mix, you know, that relate to government scheme that came down to 83% from 84%.

Park Medi World · Concall Transcript · Feb 2026 · p.12
Massive Capacity Addition Cycle
66/100

Execution is on track with 660 beds (Agra and Panchkula) being commissioned in Q4 FY26. Management has a clear roadmap for FY27 (500 beds) and FY28 (850 beds) and is maintaining a low blended capex of INR 30-35 lakhs per bed. (2 stable, 1 high-severity)

In FY ‘28, we will be aspiring for 850 beds... which should take us to roughly 5,260 beds.

Park Medi World · Concall Transcript · Feb 2026 · p.6
Tier-2/3 City Hospital Expansion
54/100

The competitive threat is stable. Park remains the second largest private chain in North India, but still trails significantly behind Max Healthcare in total bed count. (1 stable)

Today, Park Hospital stands as the largest private hospital chain in Haryana, and North India's second-largest private chain hospital.

Park Medi World · Concall Transcript · Feb 2026 · p.3
M&A of Regional Hospital Chains
51/100

Management demonstrated a successful turnaround with the Mohali acquisition (36x revenue jump in 30 months) and is applying the same model to the Agra acquisition, which is already seeing revenue growth from INR 1cr to INR 21-23cr per month. (1 easing, 1 stable)

See, when we have been generally seeing the distress assets, largely if I talk about the brownfield acquisitions, these assets have been in severe distress.

Park Medi World · Concall Transcript · Feb 2026 · p.14
New Bed Maturity Timeline
51/100

While Q3 margins are typically subdued, the company maintained a 26% EBITDA margin for the 9-month period. Management expects to sustain 26-27% EBITDA margins long-term as new beds mature. (1 stable, 1 easing)

New hospitals typically has a gestation period of 12 to 24 months

Park Medi World · Investor PPT · Feb 2026 · p.22

See the full cited Risk analysis of Park Medi World

Create free account →
Filing Analysis by Period

Park Medi World analysis by filing period

AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.